96-17063. Manfacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 61, Number 130 (Friday, July 5, 1996)]
    [Notices]
    [Page 35265]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-17063]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    Drug Enforcement Administration
    
    
    Manfacturer of Controlled Substances; Notice of Application
    
        Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on May 13, 1996, Dupont 
    Pharmaceuticals, The Dupont Merck Pharmaceutical Company, 1000 Stewart 
    Avenue, Garden City, New York 11530, made application to the Drug 
    Enforcement Administration (DEA) for registration as bulk manufacturer 
    of the basic classes of controlled substances listed below:
    
    ------------------------------------------------------------------------
                                 Drug                               Schedule
    ------------------------------------------------------------------------
    Oxycodone (9143)..............................................        II
    Hydrocodone (9193)............................................        II
    Oxymorphone (9652)............................................        II
    ------------------------------------------------------------------------
    
        The firm plans to manufacture the listed controlled substances to 
    make finished products.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the above application.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration, United States Department of Justice, 
    Washington, D.C. 20537, Attention: DEA Federal Register Representative 
    (CCR), and must be filed no later than September 3, 1996.
    
        Dated: June 27, 1996.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 96-17063 Filed 7-3-96; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
07/05/1996
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
96-17063
Pages:
35265-35265 (1 pages)
PDF File:
96-17063.pdf